Osimertinib in Subjects With Advanced Non-Small Cell Lung Cancer EGFR-T790M Mutation-positive

NCT03790397 · clinicaltrials.gov ↗
COMPLETED
Status
169
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Fundación GECP